Banner I International Workshop Genomic Testing in Cancer

This workshop aims to develop a theoretical and practical framework for the presentation of the most relevant and novel genetic approaches for the personalized diagnosis and treatment of cancer.

In this workshop, relevant key opinion leaders will present the most updated strategies for cancer management, from immunotherapy to biomarkers, clinical trials and the standard of care of the most frequent solid malignancies.

Oriented to clinical oncologists and other medical professionals involved in cancer management, this workshop aims to be an update on the techniques and strategies, both at the laboratory and the clinical oncology setting.

We are willing to receive you in Pamplona, for a fruitful learning based on clinical cases, presentations and discussion with leading experts in oncology at the “I International Workshop on Genomic Testing in Cancer”

Imagen Dr. Ignacio Gil Bazo, Departamento de Oncologia Medica.
In this workshop, relevant key opinion leaders will present the most updated strategies for cancer management".

Dr. Ignacio Gil-Bazo

Director of Medical Oncology Department. Co-director of the Lung Cancer Unit. Clínica Universidad de Navarra

Imagen del Dr. Ignacio Witsuba, Director of the Thoracic Molecular Pathology Lab, Departments of Pathology and Thoracic/Head & Neck, Medical Oncology
This workshop aims to be an update on the techniques and strategies, both at the laboratory and the clinical oncology setting".

Ignacio I. Wistuba, MD

Department Chair, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center

Venue
Center for Applied Medical Research (CIMA) of the University of Navarra
Campus Universitario
31009 Pamplona. Navarra (Spain)

Contact:

Carmen Lacosta. clacosta@unav.es

Icono azul download SCIENTIFIC PROGRAM

Co-Chairs

  • Ignacio Wistuba MD
  • Ignacio Gil-Bazo MD, PhD
     
  • Luis M. Montuenga, PhD
  • Xabier Agirre, PhD
  • María José Calasanz, PhD
  • Ana Patiño, PhD
  • Rubén Pío, PhD
  • José Ignacio Echeveste, MD, PhD
  • Mariano Ponz-Sarvisé, MD, PhD

Program

16:00 – 17:30h Welcome

  • Hilario E. Mata. Director, Global Academic Programs. MD Anderson Cancer Center Houston
  • Ruth Vera (Vice President, Sociedad Española de Oncología Médica)
  • José Andrés Gómez Cantero (General Director. Clínica Universidad de Navarra. Spain).
  • Ignacio Wistuba (Co-Chair, I International Workshop; MD Anderson Cancer Center, USA)
  • Ignacio Gil-Bazo (Co-Chair, I International Workshop; CUN, Spain)

KEYNOTE SESSION

  • Chairs: Ignacio Wistuba (Co-Chair, I International Workshop; MD Anderson Cancer Center, USA), Luis Montuenga (Centro de Investigación Médica Aplicada CIMA, SPAIN) and Ignacio Gil-Bazo (CUN, SPAIN)
  • Rafael Rosell (Catalan Institute of Oncology. H. Germans Trias i Pujol, Badalona, Spain): "Genomic Testing as a Key Tool in Precision Medicine"

17:30 - 18:00h Coffee Break

18:00 – 20:00h SESSION 1: Different Techniques for Genomic Testing

  • Chairs: Xabier Agirre (CIMA, SPAIN) and Carlos de Andrea (UN, SPAIN)
  • Mª Dolores Lozano (CUN, SPAIN): “Sample management: when the tissue is the issue”
  • Margarita Sánchez-Beato Gómez (Instituto de Investigación Sanitaria Puerta de Hierro. SPAIN): “Cancer Genetics”
  • Ana Patiño (CUN, SPAIN): “Molecular analysis and different techniques”

20:00 - 21:00h Welcome Cocktail  

8:30 - 11:30h SESSION 2: Advances in Personalized Treatment of Cancer I

  • Chairs: Ignacio Gil-Bazo (CUN, SPAIN) and Marta Santisteban (CUN, SPAIN)
  • Mariano Provencio (H. Puerta de Hierro, SPAIN): "Lung Cancer as the Paradigm in Targeted Therapy"
  • Antonio González (MD Anderson Cancer Center, SPAIN): "Genomic Testing in Breast and Ovarian Cancer Treatment"
  • Joaquim Bellmunt (Dana-Farber Cancer Institute, USA): "Genomic Testing in Genitourinary Tumors"

11:30 - 12:00h Coffee Break

12:00 - 14:00h SESSION 3: Advances in Personalized Treatment of Cancer II

  • Chairs: Salvador Martín-Algarra (CUN, SPAIN) and Javier Rodríguez (CUN, SPAIN)
  • Guillem Argilés (Val d'Hebron Institute of Oncology, SPAIN): "Improving Survival in Colorectal Cancer Therapy"
  • Ana Arance (Hospital Clinic de Barcelona, SPAIN): "Advances in Targeted Therapy for Melanoma"

14:00 - 15:00h Lunch

15:00 - 18:00h SESSION 4: Genetic testing for the selection of patients for clinical trials

  • Chairs: Emiliano Calvo (Centro Integral Oncológico Clara Campal-START, SPAIN) and José Luis Pérez-Gracia (CUN, SPAIN)
  • Ignacio Wistuba (MD Anderson Cancer Center, USA): "Lessons learned from the BATTLEs"
  • Ignacio Melero (CUN, SPAIN): "New biomarkers to develop immunotherapy strategies"
  • Christian Rolfo (Antwerp University Hospital UZA, BELGIUM): "Selection of patients for clinical trials according to the molecular profile"

18:00 - 18:30h Coffee Break

18:30-20:00h SESSION 5: Practical Cases Discussion I

  • Chairs: Rubén Pío (Centro de Investigación Médica Aplicada CIMA, SPAIN) and José I. Echeveste (CUN, SPAIN)
  • Itziar Gardeazabal (CUN, SPAIN): "Breast Cancer"
  • Antonio Calles (Hospital Gregorio Marañón): "Non-Small Cell Lung Cancer"
  • José Manuel Aramendía (CUN, SPAIN): “Ovarian Cancer”

20:30h Dinner for speakers

8:30 - 10:00h SESSION 6: Practical Cases Discussion II

  • Chairs: Mariano Ponz-Sarvisé (CUN, SPAIN) and Miguel Ángel Idoate (CUN, SPAIN)
  • Leyre Zubiri (CUN, SPAIN): “Melanoma”
  • Guillem Argilés (Val d'Hebron Institute of Oncology, SPAIN): "Colorectal Cancer"
  • José María López-Picazo (CUN, SPAIN): “Tumor of Unknown Origin”

10:00 - 10:30h Coffee Break

10:30 - 13:30h SESSION 7: Future Perspectives: Ramón Areces Keynote Session

  • Chairs: Christian Rolfo (Antwerp University Hospital UZA, BELGIUM) and Alvaro González (CUN, SPAIN)
  • Ignacio Wistuba (MD Anderson Cancer Center, USA): "Next generation sequencing in cancer: what’s next?"
  • Marileila Varella-García (University of Colorado, USA): "Novel clinical applications of genomic testing in cancer"
  • María José Serrano (GENYO, SPAIN): "The role of liquid biopsy in genomic testing in cancer"
  • Alan Nelson (Visiongate, Inc. Phoenix, Arizona): "The predictive role of 3D structural biomarkers in cells from liquid biopsy: breast cancer in blood; lung cancer in sputum”

13:30 – 13:45h Closing Remarks

ORGANIZERS:

Imagen del logotipo de la Clínica Universidad de Navarra
Imagen del logotipo del MD Anderson Cancer Center

   

Imagen del logotipo de CIMA, Centro de Investigación Médica Aplicada
Imagen del logotipo de Idisna, Instituto Sanitario de Navarra

SPONSORED BY:

Imagen del logotipo de Lilly, laboratorio farmacéutico
Imagen del logotipo de CIMA Lab Diagnostics
Imagen del logotipo de Bristol Myers Squibb
Imagen del logotipo de la Fundación Ramón Areces
Imagen del logotipo de la farmacéutica Roche
Imagen del logotipo de la farmacéutica Astellas Pharma
Imagen del logotipo de Pfizer y Merck
Imagen del logotipo de la farmacéutica Boehringer Ingelheim

tal vezle interese

POR QUÉ VENIR A
LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra

ESTANCIAS
FORMATIVAS

La Clínica ofrece la posibilidad de realizar estancias en los departamentos para así completar la formación.

Imagen de profesionales trabajando en la Clínica Universidad de Navarra

ACTIVIDAD
INVESTIGADORA

Nuestros profesionales siguen investigando y tienen a su disposición todas las instalaciones y recursos de la Universidad de Navarra.

Imagen de un investigador del Área de Terapia Celular de la Clínica Universidad de Navarra